Abstract:Introduction: Patients who are considered high-risk for choledocholithiasis after biochemical testing and abdominal ultrasound (AUS) are recommended to undergo endoscopic retrograde cholangiopancreatography (ERCP) with others to receive less invasive tests. The aim of the study is to determine whether high-risk patients by ASGE guidelines or other factors can accurately identify those with choledocholithiasis.Table 1: Diagnostic Performance of ASGE High-Risk Group and Other Test Characteristics in Patients with Suspected Choledocholithiasis ( N =2,726)Methods: Consecutive patients hospitalized (1/2011-12/2013) with suspected choledocholithiasis who received biochemical testing, AUS and definitive testing for choledocholithiasis (magnetic resonance cholangiopancreatography (MRCP), endoscopic ultrasound (EUS), ERCP, interventional radiology procedure and/or intraoperative cholangiogram (IOC)) at Sir Run Run Shaw Hospital were retrospectively identified. Patients with choledocholithiasis on AUS, bilirubin >4mg/dL, bilirubin >1.8mg/dL + dilated common bile duct (CBD) (>8mm and >6mm with or without prior cholecystectomy) and/or suspected cholangitis (presenting fever and/or leukocytosis) were considered high-risk per ASGE guidelines. Final diagnosis was based on choledocholithiasis identified on definitive testing. Results: Mean age of 2,726 patients with suspected choledocholithiasis was 55+15 yrs, 1,179 (43%) were male and 216 (8%) had prior cholecystectomy. On definitive testing (MRCP in 2,441 (90%), EUS in 69 (3%), interventional radiology procedure in 2, ERCP in 643 (23%), IOC in 189 (7%)), 1,076 (39%) patients had choledocholithiasis. A higher proportion of patients meeting ASGE high-risk criteria compared to other groups (770/1,271 (61%) vs. 306/1,455 (21%); OR=5.8, 95%CI 4.9-6.8) had confirmed choledocholithiasis. Diagnostic performance of test characteristics is shown (Table). On multivariate analysis, choledocholithiasis on AUS (AOR=17.4, 95%CI 12.6-23.9), bilirubin >4mg/dL (AOR=3.0, 95%CI 2.2-4.1) and bilirubin 1.8-4mg/dL (AOR=1.8, 95%CI 1.4-2.4) compared to < 1.8mg/dL and CBD dilation (AOR=1.8, 95%CI 1.5-2.2) increased the likelihood of choledocholithiasis. Conclusion: In patients with suspected choledocholithiasis, the specificity of high-risk group categorized by ASGE guidelines was suboptimal. Combination of factors that include choledocholithiasis on AUS and bilirubin >4mg/dL with or without CBD dilation had high specificities of >90% and moderate to high positive likelihood ratios. A revised algorithm with more stringent criteria may improve patient selection and reduce the risk of diagnostic ERCP.

Will Roux-en-Y Hepaticojejunostomy Help Prevent Calculus Recurrence in Hepatolithiasis Patient with Sphincter of Oddi Laxity: an Ongoing Randomized Controlled Trial

Laparoscopic Hepatectomy for Hepatolithiasis: a Feasibility and Safety Study in 29 Patients

Suboptimal Specificity of Asge High-Risk Group in Evaluation of Patients with Suspected Choledocholithiasis

Sphincter of Oddi Laxity: an Important Factor in Hepatolithiasis

Oddi sphincter preserved cholangioplasty with hepatico-subcutaneous stoma for hepatolithiasis

Is Oddi Sphincterotomy an Indication for Hepatolithiasis?

Mid-and Long-term Outcomes of Oddi Sphincter-preserved Cholangioplasty with Hepatico-subcutaneous Stoma(OSPCHS) for Hepatolithiasis:Report of 96 Cases

Laparoscopic approach of surgical treatment for primary hepatolithiasis: a cohort study

Endoscopic or laparoscopic approach for hepatolithiasis in the era of endoscopy in China

Long‐term Outcomes of Surgical Approaches for Bilateral Hepatolithiasis: A Real‐world Six‐decade Experience at a Single Center

Total laparoscopic partial hepatectomy versus open partial hepatectomy for primary left-sided hepatolithiasis: study protocol for a randomized controlled trial

Assessing outcomes and complications of secondary hepatolithiasis after choledochoenterostomy: A nationwide survey in Japan

Reappraisal of percutaneous transhepatic cholangioscopic lithotomy for primary hepatolithiasis

Long-Term Prognosis of Cholecystocholedocholithiasis in Chinese Population

Choledochoscopic lithotripsy is a useful adjunct to laparoscopic common bile duct exploration for hepatolithiasis: a cohort study

Prevalence, Risk Factors, and Complications of Cholelithiasis in Adults With Short Bowel Syndrome: A Longitudinal Cohort Study

Long‐term outcomes of endoscopic ultrasound‐guided hepaticogastrostomy in patients with malignant biliary obstruction

Intermediate Likelihood of Choledocholithiasis: Do All Need EUS or MRCP?

Averting an Unnecessary Revision of a Roux-en-Y Hepaticojejunostomy by Surgically Creating an Access Point for the Endoscopic Assessment of the Anastomosis: A Report of a Case

Comparison of Laparoscopic Versus Open Left Lateral Hepatectomy for Hepatolithiasis in China

Treatment for recurrent choledocholithiasis: endoscopic? or laparoscopic? A prospective cohort study